Report cover image

Tramadol Market

Publisher Fortune Business Insights Pvt. Ltd.
Published Sep 01, 2024
Length 150 Pages
SKU # FOB19185740

Description

Tramadol Market



Growth Factors of Tramadol Market

The tramadol market size was valued at USD 2.11 billion in 2023, and the market is now projected to grow from USD 2.22 billion in 2024 to USD 3.50 billion by 2032, exhibiting a CAGR of 5.8% during the forecast period of 2024-2032.

The tramadol market suffered because of the COVID-19 pandemic as patients were unable to visit doctors or receive prescriptions for surgeries. But after the year 2022 the market again returned to normal with moderate CAGR expected as most of the hospital surgeries started and prescriptions of pain management drugs were enhanced.

It has been noticed that cases of chronic diseases and surgeries hence the need to use tramadol have triggered by change in lifestyles and increased aging population. The rise in incidence of different kinds of pain such as neuropathic, dental and post-surgical pains shall give an impetus to the use of tramadol for managing the pains.

A global tramadol market has emerged since it works as an analgesic and is used widely in different indications. New product approvals and product launches by the market players are rapidly contributing to the growth for treating various medical conditions that were earlier unaddressed and expanding the application of the drug.

Comprehensive Analysis of Tramadol Market

The tramadol market growth is rising at an exponential rate due to its market segmentation. This market expansion correctly offers a detailed nearby assessment considering the dominant supply and demand forces that impact the industry. These segmentations are methodically segregated by dosage form analysis and by distribution channel analysis. By dosage form analysis include tablets, capsules, injections, and others. By distribution channel analysis include hospital pharmacies, retail pharmacies, and online pharmacies.

The Asia Pacific region lead the tramadol market share by benefitting a market size of USD 1.05 billion in 2023 due to high demand for pain management drugs.

The top players in the markets have a central responsibility in the healthcare industry to be sure of industrial prospectus development and to establish the market norms. These players include, Grünenthal, Mundipharma International, Zydus Group, GSK plc, Vertical Pharmaceuticals, LLC, Janssen Global Services, LLC, Cipher Pharmaceuticals Inc. these market players provide a level-playing competitive landscape.

In April 2023, Cipher Pharmaceuticals Inc. attended the Bloom Burton & Co. Healthcare Investor Conference to showcase its product portfolio and expand its global presence.

Segmentation Table

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Unit Value (USD billion)

Growth Rate CAGR of 5.8% from 2024-2032

Segmentation By Dosage Form

- Tablets

- Capsules

- Injections

- Others

By Distribution Channel

- Hospital Pharmacies

- Retail Pharmacies

- Online Pharmacies

By Geography

- North America (By Dosage Form, By Distribution Channel, and By Country)

- U.S.

- Canada

- Europe (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)

- U.K.

- Germany

- France

- Spain

- Italy

- Rest of Europe

- Asia Pacific (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)

- Japan

- China

- India

- Australia

- Rest of Asia Pacific

- Latin America (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)

- Brazil

- Mexico

- Rest of Latin America

- Middle East & Africa (By Dosage Form, By Distribution Channel, and By Country/Sub-Region)

- GCC

- South Africa

- Rest of Middle East & Africa


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

150 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Key Chronic Diseases, By Key Countries/ Regions, 2023
4.2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
4.3. Pipeline Analysis
4.4. Impact of COVID-19 on the Tramadol Market
5. Global Tramadol Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Dosage Form
5.1.1. Tablets
5.1.2. Capsules
5.1.3. Injections
5.1.4. Others
5.2. Market Analysis, Insights and Forecast – By Distribution Channel
5.2.1. Hospital Pharmacies
5.2.2. Retail Pharmacies
5.2.3. Online Pharmacies
5.3. Market Analysis, Insights and Forecast – By Region
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. Latin America
5.3.5. Middle East & Africa
6. North America Tramadol Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Dosage Form
6.1.1. Tablets
6.1.2. Capsules
6.1.3. Injections
6.1.4. Others
6.2. Market Analysis, Insights and Forecast – By Distribution Channel
6.2.1. Hospital Pharmacies
6.2.2. Retail Pharmacies
6.2.3. Online Pharmacies
6.3. Market Analysis, Insights and Forecast – By Country
6.3.1. U.S.
6.3.2. Canada
7. Europe Tramadol Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Dosage Form
7.1.1. Tablets
7.1.2. Capsules
7.1.3. Injections
7.1.4. Others
7.2. Market Analysis, Insights and Forecast – By Distribution Channel
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
7.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.3.1. U.K.
7.3.2. Germany
7.3.3. France
7.3.4. Spain
7.3.5. Italy
7.3.6. Rest of Europe
8. Asia Pacific Tramadol Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Dosage Form
8.1.1. Tablets
8.1.2. Capsules
8.1.3. Injections
8.1.4. Others
8.2. Market Analysis, Insights and Forecast – By Distribution Channel
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.3.1. Japan
8.3.2. China
8.3.3. India
8.3.4. Australia
8.3.5. Rest of Asia Pacific
9. Latin America Tramadol Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Dosage Form
9.1.1. Tablets
9.1.2. Capsules
9.1.3. Injections
9.1.4. Others
9.2. Market Analysis, Insights and Forecast – By Distribution Channel
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
9.3.1. Brazil
9.3.2. Mexico
9.3.3. Rest of Latin America
10. Middle East & Africa Tramadol Market Analysis, Insights and Forecast, 2019-2032
10.1. Market Analysis, Insights and Forecast – By Dosage Form
10.1.1. Tablets
10.1.2. Capsules
10.1.3. Injections
10.1.4. Others
10.2. Market Analysis, Insights and Forecast – By Distribution Channel
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.2.3. Online Pharmacies
10.3. Market Analysis, Insights and Forecast – By Country/ Sub-Region
10.3.1. GCC
10.3.2. South Africa
10.3.3. Rest of Middle East & Africa
11. Competitive Analysis
11.1. Global Market Share Analysis (2023)
11.2. Company Profiles
11.2.1. Grünenthal
11.2.1.1. Overview
11.2.1.2. Products & Services
11.2.1.3. SWOT Analysis
11.2.1.4. Recent Developments
11.2.1.5. Strategies
11.2.1.6. Financials (Based on Availability)
11.2.2. Mundipharma International
11.2.2.1. Overview
11.2.2.2. Products & Services
11.2.2.3. SWOT Analysis
11.2.2.4. Recent Developments
11.2.2.5. Strategies
11.2.2.6. Financials (Based on Availability)
11.2.3. Zydus Group
11.2.3.1. Overview
11.2.3.2. Products & Services
11.2.3.3. SWOT Analysis
11.2.3.4. Recent Developments
11.2.3.5. Strategies
11.2.3.6. Financials (Based on Availability)
11.2.4. GSK plc
11.2.4.1. Overview
11.2.4.2. Products & Services
11.2.4.3. SWOT Analysis
11.2.4.4. Recent Developments
11.2.4.5. Strategies
11.2.4.6. Financials (Based on Availability)
11.2.5. Vertical Pharmaceuticals
11.2.5.1. Overview
11.2.5.2. Products & Services
11.2.5.3. SWOT Analysis
11.2.5.4. Recent Developments
11.2.5.5. Strategies
11.2.5.6. Financials (Based on Availability)
11.2.6. Janssen Global Services, LLC
11.2.6.1. Overview
11.2.6.2. Products & Services
11.2.6.3. SWOT Analysis
11.2.6.4. Recent Developments
11.2.6.5. Strategies
11.2.6.6. Financials (Based on Availability)
11.2.7. Cipher Pharmaceuticals Inc.
11.2.7.1. Overview
11.2.7.2. Products & Services
11.2.7.3. SWOT Analysis
11.2.7.4. Recent Developments
11.2.7.5. Strategies
11.2.7.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us